BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Sunday, March 15, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Jan. 15, 2016

View Archived Issues

Mayo Clinic investigates stem cell coated fistula plug in cryptoglandular perianal fistulas

Read More

Bayer initiates phase I of BAY-1862864 in relapsed or refractory CD22-positive NHL

Read More

First-in-human trial investigates GSK-3008348 for idiopathic pulmonary fibrosis

Read More

Roche starts phase I trial of anti-HBV candidate RO-7020322

Read More

Adimab announces updates on recent partnerships and development milestones

Read More

New collaboration agreements in oncology

Read More

NeuroVive enters into a strategic research partnership with University of Pennsylvania

Read More

Moderna Therapeutics outlines pipeline progress and goals for the year ahead

Read More

Kowa plans cardiovascular outcomes trial of K-877

Read More

NIH funds 24 research projects to develop non-traditional therapeutics for bacterial infections

Read More

ONO submits a manufacturing and marketing approval application for ONO-5163 in Japan

Read More

FDA issues complete response letter for BioMarin's Kyndrisa

Read More

Sanofi Pasteur will provide key funding and support to the Human Vaccines Project

Read More

Bionaturis to take part in two initiatives

Read More

New York Genome Center to investigate genetic basis of autism

Read More

BMPR1B-Fc chimera shows bone-increasing effects without toxicity

Read More

ALK reports results from trial examining Grazax in the prevention of asthma in children

Read More

Boehringer Ingelheim discloses Mdm2-p53 interaction inhibitors

Read More

Esteve announces sigma1-receptor ligands

Read More

University of Texas System patents agents for African trypanosomiasis

Read More

UNAM discloses antidepressants from Casimiroa pubescens

Read More

Katholieke Universiteit Leuven and UCB present PI4KIII-beta inhibitors

Read More

Bayer Schering Pharma announces BUB1 inhibitors

Read More

Intellia launches eXtellia to develop ex vivo gene therapies using CRISPR/Cas9 technology

Read More

Implantable synthetic converter cells, a promising strategy to treat psoriasis

Read More

PET tracer [18F]RO-6958948 shows promise to assess tau pathology in AD

Read More

Inhibition of MyD88 signaling might prevent colitis-associated colorectal cancer

Read More

FDA grants orphan drug designation to gene therapy for critical limb ischemia

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for March 13, 2026.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for March 10, 2026
  • MSD synthesizes α-synuclein PET agents

    BioWorld Science
    Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
  • Illustration of a motor neuron

    Keros reports beneficial effects of RKER-065 in ALS model

    BioWorld Science
    Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
  • GWAS identifies variant associated with diabetic retinopathy and susceptibility to T2D

    BioWorld Science
    Scientists at the University of Nottingham Ningbo China and collaborators aimed to identify genetic variants associated with diabetic retinopathy.
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing